Background: A number of obstetric patients choose to avoid blood products. These women are known to be at increased risk of maternal morbidity and mortality and can present a challenge in obstetric practice in regards to managing a potentially catastrophic haemorrhage. It is vital that each of these women have an individualised management plan to identify the components, products and alternatives that each woman will accept in advance to the risky peripartum period. These individualised management plans typically involve a review by an expert staff, antenatal iron optimisation and a peripartum delivery/blood management plan. This audit aims to review the delivery of the care bundle and to collate selected outcomes of these women at King Edward Memorial Hospital, a level 6 Obstetrics Hospital between 2016 to 2018.
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Methods: All medical records of obstetric patients that decline blood products since the revision of the KEMH 'Management of refusal of blood products and/or components" guideline in June 2016 will be reviewed. Data collection includes information on referral to the Haematology service, if a documented management plan (MR295.99) has been completed, if the patient identifies as a Jehovah's witness, 1st trimester haemoglobin + ferritin, use of oral iron tablets/iron infusions antenatally, 3rd trimester haemoglobin + ferritin, postnatal haemoglobin, interventions used as described above, caesarean section rate, and admission to ICU/ASCU.
Results: Audit is currently underway. Results yet to be published.
Conclusions: Audit is currently underway. Conclusions yet to be published. Background: Early intestinal microbiota development is complex, influenced by feeding and many perinatal factors such as delivery mode. We evaluated gut microbiota maturation in fullterm breastfed infants and contrasted between those born by Caesarean Section (CS) or vaginal delivery (VD).
INFLUENCE OF DELIVERY MODE ON GUT MICROBIOTA DEVELOPMENT IN BREASTFED TERM INFANTS DURING THE FIRST YEAR OF LIFE
Methods: Stool samples from 42 term infants (17 CS; 25 VD), who were exclusively breastfed for at least the first 4 months of life, were collected at week 1, week 4, and at 4 and 12 months of age. 16S rRNA sequencing was used to investigate the microbiota.
Results: Firmicutes and Proteobacteria were the main dominant phyla at both week 1 and 4 whereas Actinobacteria and Firmicutes at 4 month, and Bacteroidetes and Firmicutes at 1 year of age. CS is associated with a significant higher ratio of facultative to strict anaerobe during the first 4 months of life. CS is associated with a higher abundance of Firmicutes and Proteobacteria and a lower abundance of Actinobacteria and Bacteroidetes compared with VD. Delivery mode had an effect on β-diversity that VD and CS samples clustered away from each other in the multidimensional plot, more obvious at week-4 than week-1. At 4 months, VD and CS samples started to cluster close to each other. By year 1, samples from all groups showed the same distribution within the multidimensional plot.
Conclusions: In exclusively breastfed infants, early microbiota development is influenced by delivery mode. As microbiota maturation during the first few months of life may be crucially linked to immunological development, its significance needs further evaluation. Background: Early macronutrient supplementation of infants born small may improve growth and neurodevelopment but have detrimental effects on later cardio-metabolic health. Animal studies have also reported sex-specific differences in the impact of early nutritional interventions. Our aim was to evaluate the evidence about the long-term effects of macronutrient supplementation in preterm and small-for-gestational age (SGA) animals and whether these differ in males and females.
MACRONUTRIENT SUPPLEMENTS IN PRETERM OR SMALL-FOR-GESTATIONAL-AGE ANIMALS; A SYSTEMATIC REVIEW AND META-ANALYSIS
Method: We used Cochrane Neonatal Review Group and SYRCLE methodology. Included studies used random or quasirandom methods to feed macronutrient supplements to nonhuman mammals between birth and weaning and assessed postweaning outcomes. Two reviewers independently screened, abstracted data and assessed evidence quality. We reported our findings in age groups (infancy, juvenile, puberty, young adult and older adult).
Results: Five studies (198 animals, range 32-60) were included. Low to very-low quality evidence showed that macronutrient supplementation increased weight in juveniles (standardised mean difference; 95% confidence intervals: 2.13; 1.00, 3.25; 1 study, n = 24 rats) but not overall. There was no evidence of an overall effect on length, body composition, or plasma insulin, glucose or lipid concentrations. Macronutrient supplementation decreased leptin concentrations in young adults (−1.13; −2.21, −0.05; 1 study, n = 16 female rats) but increased leptin concentrations in older adults (1.31; 0.12,2.51; 1 study, n = 14 male rats).
Conclusion: Macronutrient supplements given to preterm and SGA animals may have sex-specific effects on later growth and metabolic health. However, with paucity of data and verylow quality evidence, further research is needed.
